Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shmuel Chen

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|February 16, 2018
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL TrialIoanna Kosmidou, Shmuel Chen, A Pieter Kappetein, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2019
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventionsTamim M Nazif, Shmuel Chen, Pablo Codner, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
European Heart Journal|September 11, 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trialTamim M Nazif, Shmuel Chen, Isaac George, et al.
The American Journal of Cardiology|September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
International Journal of Cardiology|September 13, 2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Shmuel Chen, et al.
European Heart Journal|March 29, 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trialOri Ben-Yehuda, Shmuel Chen, Björn Redfors, et al.
Journal of the American Heart Association|August 11, 2021
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched AnalysisMichael I Brener, Anna Olds, Samantha Nemeth, et al.
JACC. Cardiovascular Interventions|April 3, 2022
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT RegistryMatheus Simonato, Sreekanth Vemulapalli, Ori Ben-Yehuda, et al.
Thrombosis and Haemostasis|December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and MethodologyBehnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|February 16, 2018
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL TrialIoanna Kosmidou, Shmuel Chen, A Pieter Kappetein, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2019
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventionsTamim M Nazif, Shmuel Chen, Pablo Codner, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
European Heart Journal|September 11, 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trialTamim M Nazif, Shmuel Chen, Isaac George, et al.
The American Journal of Cardiology|September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
International Journal of Cardiology|September 13, 2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Shmuel Chen, et al.
European Heart Journal|March 29, 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trialOri Ben-Yehuda, Shmuel Chen, Björn Redfors, et al.
Journal of the American Heart Association|August 11, 2021
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched AnalysisMichael I Brener, Anna Olds, Samantha Nemeth, et al.
JACC. Cardiovascular Interventions|April 3, 2022
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT RegistryMatheus Simonato, Sreekanth Vemulapalli, Ori Ben-Yehuda, et al.
Thrombosis and Haemostasis|December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and MethodologyBehnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Pageof 10